> News > Company News

Company News

2024 CPHI CHINA Shanghai

We are pleased to inform you that we will be attending CPHI CHINA 2024 from June 19 to 21, 2024, our booth number is W7B56.

Who is more effective, Elamod or Methotrexate

Medications are often used as one of the means to treat rheumatoid arthritis, and drugs such as Elamod and Methotrexate are also commonly used to treat rheumatoid arthritis.

Pharmacological characteristics of dexmedetomidine and its application in postoperative delirium in elderly patients

Postoperative delirium refers to the delirium that occurs in patients after undergoing surgical procedures. Its main characteristics are disturbances in consciousness levels and cognitive impairment, with large fluctuations in the condition and a relatively short course of illness.

Sodium nitroprusside and urapidil, both antihypertensive drugs, have different contraindications and adverse reactions!

Recently, a doctor in the department changed the sodium nitroprusside used for blood pressure reduction to urapidil. Due to the less significant antihypertensive effect of urapidil compared to sodium nitroprusside, it cannot effectively inhibit the increase of blood pressure when using the same dosa......

Announcement of Jiangsu Run'an Pharmaceutical Co., Ltd. before the 2023 Clean Production Audit

According to the requirements of the Clean Production Promotion Law of the People's Republic of China and the Clean Production Audit Measures, we hereby publicly disclose the basic information of our company's enterprises and the production and pollution discharge status before the audit.

Chen Zhichang, Secretary of the Municipal Party Committee, conducted research on the construction of the new factory area of Zhengda Qingjiang Pharmaceutical

On the morning of August 22nd, Chen Zhichang, Secretary of the Municipal Party Committee, led a team to conduct on-site research on the construction site of the new factory area project of Zhengda Qingjiang Pharmaceutical.

<1 2 3 >